Company Cash on Hand: beigene.com (ONC)

Corporate emblem and logo of BeiGene Ltd. (ONC)

BeiGene Ltd efficiency is based on the expansion of Brukinsa and the optimization of R&D costs. The cash balance visualizes the dynamics of liquid reserves, where the indicator value is 5.83. This ensures access to the global healthcare markets of the US and China, while stable demand for targeted therapy guarantees an inflow of high-margin cash and operational business resilience.

Company Cash Funds: BeiGene Oncology (ONC) for 07/04/2022 - 11/21/2026

BeiGene Ltd. (ONC) - metric breakdowns and financial figures

- stock quotes and analyst forecast:
- company stock exchange capitalization indicators:
- cash position and cash flow details:
Analysis of all company metrics:ONC BeiGene
Brand item of BeiGene

For the long-term investor, the financial stability of BeiGene Ltd (ONC) is determined by its ability to fund R&D without emergency borrowing. This metric tracks the daily balance of liquid assets, reflecting the rate of capital burn. By analyzing the company's cash position, one can assess the risk of a liquidity gap prior to drug commercialization. A sufficient reserve guarantees the completion of costly clinical trials, ensuring future business scalability through global sales.

Who BeiGene Ltd competes with

Company Cash on Hand HALO (Halozyme Therapeutics, Inc.)|Company Cash Volume Revolution Medicines, Inc. (RVMD)|Company Cash Volume AAPG (ascentage.com)|CG Oncology Inc (CGON) - Company Cash Reserve|URGN - Company Cash Funds|Bicara Bio - Company Total Cash Amount|PSNL: Company Cash Volume|Company Cash and Cash Equivalents ERAS|Company Cash on Hand DCTH|Company Cash Reserve Y-mAbs Therapeutics Inc YMAB|Company Cash Volume AURA|CADL (Candel Therapeutics, Inc.) - Company Cash Balance|Company Cash Funds Accuray Inc ARAY|Company Liquid Assets SELLAS Life Sciences Group Inc. (SLS)|actuatetherapeutics.com - Company Cash Volume|Company Cash Reserve Citius Oncology|HURA: Company Cash Volume|Company Total Cash Volume TARA (Protara)|FATE (fatetherapeutics.com) - Company Cash Volume|Company Cash Reserve Aadi Bioscience WHWK|Company Cash Volume TCRX|CSBR - Company Cash Reserve|XBiotech - Company Cash on Hand|CEL-SCI Corporation (CVM) - Company Cash Reserve|OSTX - Company Cash Funds|Company Cash Reserve Radiopharm Theranostics Ltd|ARTV (artivabio.com) - Company Cash on Hand|ANL (Adlai Nortye Ltd) - Company Cash Funds|Company Cash on Hand VERU|Tempest Therapeutics (TPST) - Company Liquid Assets|Company Cash Volume XLO|Company Cash on Hand Renovaro RENB|Company Cash Volume MURA (Mural Oncology PLC)|KAPA - Company Cash on Hand|OnKure Therapeutics - Company Cash Volume|w2.cytomed.sg - Company Total Cash Amount|Curis Corp (CRIS) - Company Cash Funds|Company Cash Reserve Apollomics Corp (APLM)|Company Cash Funds Tharimmune|Company Cash Volume advanbiomed.com|Company Cash Funds Genprex, Inc (GNPX)|Company Liquid Assets Calidi Biotherapeutics, Inc.|Company Cash Volume SBFM (Sunshine Biopharma Inc.)|XBIO - Company Cash on Hand|SLRX: Company Cash on Hand|Company Cash Balance PPBT (Purple Biotech Ltd.)|AONC: Company Cash Volume|Company Cash Reserve BeOne Medicines (BGNE)|Company Cash Funds Checkpoint Therapeutics, Inc.|Company Cash on Hand Elevation Oncology (ELEV)|Company Cash Funds iCAD Corp (ICAD)|Company Cash on Hand Ikena IKNA|Company Cash Volume NTBL (notablelabs.com)|VIRX - Company Cash on Hand|MOR: Company Cash on Hand|NAYA - Company Cash Volume|Ascentage Pharma (AAPGV) - Company Cash Funds